Target intelligence / Profile preview

78 kDa gastrin-binding protein (GBP)

Target
GBP
Molecular classification
Enzyme, Receptor, Binding protein
01

Overview

The 78 kDa gastrin-binding protein (GBP) is a high-affinity binding site for the hormone gastrin, primarily identified in the gastric mucosa and various gastrointestinal tissues (Baldwin et al., 1994, J Biol Chem). Molecular characterization has revealed that this protein is identical to the peroxisomal bifunctional enzyme, enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase (EHHADH) (UniProt Q08426). While its primary metabolic function involves the second and third steps of the peroxisomal fatty acid beta-oxidation pathway, it also localizes to the cell membrane where it may mediate the trophic effects of gastrin (He et al., 2001, Biochem J). The 78 kDa GBP is significantly overexpressed in colorectal, gastric, and pancreatic cancers, where it is thought to promote cell proliferation and tumor growth independently of the classical Cholecystokinin B receptor (CCKBR) (Smith & Watson, 2000, Aliment Pharmacol Ther). As a potential therapeutic target, research has focused on using antisense oligonucleotides or specific antibodies to inhibit its expression or activity in gastrointestinal malignancies (Baldwin, 1995, Progress in Nucleic Acid Research and Molecular Biology). However, targeting this protein poses significant safety concerns due to its essential role in systemic lipid metabolism and peroxisomal function.

Other names
Gastrin-binding proteinEnoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenaseEHHADHL-bifunctional enzymep78Peroxisomal bifunctional enzyme
02

Mechanism of action

Antagonism of gastrin binding to the 78 kDa GBP to inhibit gastrin-stimulated cellular proliferation in gastrointestinal tumors.

03

Biological functions

Signal transductionCell proliferationFatty acid beta-oxidationGastrin binding
04

Disease associations

Colorectal cancerGastric cancerPancreatic cancer
05

Safety considerations

Peroxisomal dysfunctionMetabolic toxicity
06

Interacting drugs

Gastrin-17

2 more in the full profile.

07

Biomarkers

GBP expressionEHHADH expression

Beyond the preview

Go deeper on 78 kDa gastrin-binding protein (GBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 78 kDa gastrin-binding protein (GBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call